Crossmark

Profiling of IgG antibodies targeting unmodified and corresponding citrullinated autoantigens in a multicenter national cohort of early arthritis in Germany

Crossref DOI link: https://doi.org/10.1186/s13075-020-02252-6

Published Online: 2020-07-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vordenbäumen, Stefan https://orcid.org/0000-0001-5725-5483
Brinks, Ralph

Schriek, Patrick

Lueking, Angelika

Richter, Jutta G.

Budde, Petra

Schulz-Knappe, Peter

Zucht, Hans-Dieter

Callhoff, Johanna

Schneider, Matthias
License Information

Text and Data Mining valid from 2020-07-06

Version of Record valid from 2020-07-06
More Information

Article History

Received: 18 December 2019

Accepted: 17 June 2020

First Online: 6 July 2020

Ethics approval and consent to participate

: The study complied with the Declaration of Helsinki. Written informed consent was obtained from all patients (Heinrich-Heine-University Medical Faculty Ethics Approval No. 3368).

: Not applicable

: SV, RB, JGR, JC, and MS declare that they have no competing interest. PS, AL, and PS-K are former employees of Protagen AG, Germany. PB and H-DZ are current employees of Oncimmune Germany GmbH (formerly Protagen AG, Germany)

Document is current

Any future updates will be listed below